Evidence map›Paper›PMID 25489752›Full record

ArticleInfection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases2015

Genomic sequences of six botulinum neurotoxin-producing strains representing three clostridial species illustrate the mobility and diversity of botulinum neurotoxin genes.

Theresa J Smith, Karen K Hill, Gary Xie, Brian T Foley, Charles H D Williamson, Jeffrey T Foster, Shannon L Johnson, Olga Chertkov, Hazuki Teshima, Henry S Gibbons and 3 more

Open access · greenAbstract read
In one paragraph

Article in Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.

  1. Guideline
  2. The unsung hero:Frontiers in cellular and infection microbiology · 2026
    Article
  3. Whole genome sequencing of neurotoxin-producingFrontiers in public health · 2025
    Article
  4. Complete genomes ofMicrobial genomics · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Comparative Genomics ofMicroorganisms · 2022
    Article
  9. Fighting Cancer with Bacteria and Their Toxins.International journal of molecular sciences · 2021
    Review
  10. Article
  11. Endogenous CRISPR-Cas Systems in Group IFrontiers in microbiology · 2021
    Article
  12. Article
  13. ClosingFrontiers in microbiology · 2020
    Article
  14. Article
  15. Article
  16. Article
  17. Genomics of the Pathogenic Clostridia.Microbiology spectrum · 2019
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Theresa J SmithMolecular and Translational Sciences Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702, United States. Electronic address: theresa.j.smith.civ@mail.mil.
Karen K HillBioscience Division, Los Alamos National Laboratory, Los Alamos, NM 87545, United States.
Gary XieBioscience Division, Los Alamos National Laboratory, Los Alamos, NM 87545, United States.
Brian T FoleyTheoretical Division, Los Alamos National Laboratory, Los Alamos, NM 87545, United States.
Charles H D WilliamsonCenter for Microbial Genetics and Genomics, Northern Arizona University, Flagstaff, AZ 86011, United States.
Jeffrey T FosterCenter for Microbial Genetics and Genomics, Northern Arizona University, Flagstaff, AZ 86011, United States.
Shannon L JohnsonBioscience Division, Los Alamos National Laboratory, Los Alamos, NM 87545, United States.
Olga ChertkovBioscience Division, Los Alamos National Laboratory, Los Alamos, NM 87545, United States.
Hazuki TeshimaBioscience Division, Los Alamos National Laboratory, Los Alamos, NM 87545, United States.
Henry S GibbonsBiosciences Division, Edgewood Chemical Biological Center, Aberdeen Proving Ground, MD 21010, United States.
Lauren A JohnskyBiosciences Division, Edgewood Chemical Biological Center, Aberdeen Proving Ground, MD 21010, United States.
Mark A KaravisBiosciences Division, Edgewood Chemical Biological Center, Aberdeen Proving Ground, MD 21010, United States.
Leonard A SmithMedical Countermeasures Technology, United States Army Medical Research and Material Command, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702, United States.
Los Alamos National Laboratory · USU.S. Army Combat Capabilities Development Command Chemical Biological CenterNorthern Arizona University · USUnited States Army Medical Research Institute of Infectious Diseases · US

Funding

Development of botulinum neurotoxin immunotherapyU01AI056493 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MARKS, JAMES D. · 2003 to 2007
$5.1M
NIAID NIH HHS U01 AI056493NIAID NIH HHS U01AI056493
6 · The paper itself

Abstract

The whole genomes for six botulinum neurotoxin-producing clostridial strains were sequenced to provide references for under-represented toxin types, bivalent strains or unusual toxin complexes associated with a bont gene. The strains include three Clostridium botulinum Group I strains (CDC 297, CDC 1436, and Prevot 594), a Group II C. botulinum strain (Eklund 202F), a Group IV Clostridium argentinense strain (CDC 2741), and a Group V Clostridium baratii strain (Sullivan). Comparisons of the Group I genomic sequences revealed close relationships and conservation of toxin gene locations with previously published Group I C. botulinum genomes. The bont/F6 gene of strain Eklund 202F was determined to be a chimeric toxin gene composed of bont/F1 and bont/F2. The serotype G strain CDC 2741 remained unfinished in 20 contigs with the bont/G located within a 1.15Mb contig, indicating a possible chromosomal location for this toxin gene. Within the genome of C. baratii Sullivan strain, direct repeats of IS1182 insertion sequence (IS) elements were identified flanking the bont/F7 toxin complex that may be the mechanism of bont insertion into C. baratii. Highlights of the six strains are described and release of their genomic sequences will allow further study of unusual neurotoxin-producing clostridial strains.

Indexed as

Botulinum ToxinsClostridiumClostridium InfectionsDNA, BacterialEnvironmental MicrobiologyFood MicrobiologyGene Transfer, HorizontalGenome, BacterialHumansMultigene FamilyPhylogenySequence AlignmentBotulinum ToxinsDNA, BacterialBotulinum neurotoxinClostridium argentinenseClostridium baratiiClostridium botulinum

Identifiers

PMID25489752
PMCPMC5459376
OpenAlexW2088975164

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.